Gilbey on Film: Sacha Baron Cohen is back

This time as dictator General Aladeen of Wadiya.

To the Royal Festival Hall on London’s South Bank, at the behest of a certain General Aladeen of Wadiya. As the invitation puts it: “His Excellency Admiral General Aladeen Would Like to Pleasure You at the World Premiere of The Dictator.” Perhaps it is this unusual promise which brought all these shiny orange people onto the red carpet on a dismal, rainy Thursday evening prior to watching the latest film from Sacha Baron Cohen. You would think their stylists would have warned them that tangerine doesn’t go with red, but here they are anyway, the cast of The Only Way Is Essex, illuminated still further in the sheet lightning from fifty photographers’ flashbulbs. No, strike that - the people behind me are saying it’s the cast of Geordie Shore. We’ll go with that. Thank you, people behind me.

Next is an abrasive wee fellow named Louis Spence. I don’t know who he is or what he’s done to warrant a place on the red carpet, but Alex Zane, the red-carpet interviewer with scissor legs, is mighty pleased to see him. What would Louis do if he were dictator of his own country? “Spit at people with speech impediments,” apparently. Oh dear. Is that an in-joke? Alex laughs, but it’s the fearful laughter of a man who sees his every media moment through the prism of the Jonathan Ross/Russell Brand scandal, wondering: “Who will be next? Could it be me?” Moving along, he interviews one of several comics currently named Russell (not Brand), who tells him that what makes Sacha Baron Cohen so brilliant is that “he finds the line and thrusts across it …He totally, schizophrenically inhabits who he becomes.”

Right on cue, here comes the film’s star as General Aladeen, arriving in front of the venue waving from the driver’s seat of an orange Lamborghini - a clamped orange Lamborghini, that is, mounted on the bed of a City of Westminster tow truck. I like his habit of only giving press interviews in character (see this email exchange with Dennis Lim of the New York Times). Even if you don’t find it funny (though personally I’m tickled by his in-character assertion that “The Arab Spring is just a silly fad, like ‘mood rings’ or ‘human rights’”), you have to concede that it’s preferable to celebrities talking about the spiritual journey which they embarked upon with their latest role. Imagine if everyone gave interviews in character. Wouldn’t that be something? Unless it was Jodie Foster in Nell, obviously. Clearly there would need to be exemptions.

Just after the lights go down, Baron Cohen appears — still in costume and in character — in a spotlight in the balcony, greeting the audience with cries of “Hello, hello, death to the West!” and “Hello, English devils”. He says he has been enjoying his red carpet experience. “Usually when I am on a red carpet it is because I have just beheaded someone in my living room.”

That’s the general tenor of the material in The Dictator, which has at its core the novel idea of an essentially innocent oppressor: a naïve, mollycoddled man who just happens to be a vicious murderer. It’s really the same joke that held together Baron Cohen’s last two films, Borat and Brüno — wide-eyed naïf comes to the US and exposes inadvertently that country’s hypocrisy and small-mindedness — but with the twist of making him a psychopath rather than merely a buffoon.

Watching The Dictator, which begins with the dedication “In Loving Memory of Kim Jong-Il”, I missed the genuinely dangerous edge of Borat and Brüno; those pictures placed Baron Cohen in volatile, real-life scenarios where his provocations almost led to violence against him. There’s no way to fake or replace it. On the other hand, that species of comedy can’t go on forever, not least because the actor is now a widely recognisable superstar, unlikely to be able to orchestrate pranks of the same scale. At least The Dictator is often wildly funny, particularly when General Aladeen, stripped of his uniform and beard, and wandering New York for reasons too convoluted to recount, has to take work in a Brooklyn feminist co-operative “for people of all or no genders” (as the store worker Zoe, played by the impish Anna Faris, puts it).

The film has teeth, which it bares occasionally. I’m not thinking so much of the bad taste gags—a terrorism Wii game, which offers Aladeen options such as “Tokyo Subway” and “London Underground” before he opts for “Munich Olympics,” drew a shocked gasp from the audience, while there’s a running gag involving a severed head, which was done better in the horror-comedy Re-Animator. But it succeeds in finding a rich vein of humour in post-9/11 paranoia. And it turns the tables on both liberalism (in its lively mockery of Zoe and her co-op pals) and the west, the latter skewered in an inspired monologue which has Aladeen showing how the US advocates at home the same cruelty it decries in foreign regimes.

"The Dictator" is released 16 May.

Sacha Baron Cohen arrives at the premiere of The Dictator (Photo: Getty Images)

Ryan Gilbey is the New Statesman's film critic. He is also the author of It Don't Worry Me (Faber), about 1970s US cinema, and a study of Groundhog Day in the "Modern Classics" series (BFI Publishing). He was named reviewer of the year in the 2007 Press Gazette awards.

Getty
Show Hide image

The best defence against Alzheimer’s

Spoiler: the best way to avoid Alzheimer's is to stay young.

At the recent meeting of the European Academy of Neurology in Copenhagen, doctors were signing up to attend a workshop teaching non-specialists to test for cognitive decline in their patients. How do you tell the difference between a scatterbrain and a case of early dementia?

It’s a question that is increasingly urgent. Last year, 47.5 million people were living with dementia. That will have risen to 75.6 million by 2030 and will reach 140 million in 2050. The World Health Organisation has declared that dementia should be regarded as a global public health priority. But what can we do about it?

The primary cause of dementia, accounting for roughly 70 per cent of cases, is Alzheimer’s disease. It’s all very well to put a name to it, but we don’t have a clear understanding of the mechanisms that cause it – or medicines to battle it. Alzheimer’s drugs have a high rate of failure. In the decade to 2012, 99.6 per cent of newly developed drugs failed to make it past clinical trials. There is no cure for Alzheimer’s and none on the horizon, either.

There was, however, a small breakthrough last month. A study published in the journal Science Translational Medicine suggests that Alzheimer’s could be a result of fighting infections from other diseases that would, if left unchecked, ravage the brain. The hard lumps of sticky plaque in the brain that characterise the onset of Alzheimer’s seem to be the result of the immune system attempting to isolate and neutralise microbes and other pathogens that have made their way into the brain. The plaques catch pathogens, preventing infection from taking hold. Unfortunately, it’s a case of damned if you do, damned if you don’t: the plaques also trigger inflammation that leads to the death of brain cells.

This observation mirrors another catch-22 with Alzheimer’s. Some researchers have suggested that the drug failures might be averted by getting candidate treatments to the disease earlier, before symptoms appear. Put simply, the drugs may stand a better chance of success when trying to counter the first stages of damage to the brain. The problem is: how do you get that early diagnosis?

There are various genetic indicators for a heightened predisposition to developing Alzheimer’s. A gene called apolipoprotein E, for instance, comes in three variants: one kind seems to reduce the risk of Alzheimer’s while another increases it. Other genes – variously associated with the body’s uptake of cholesterol, its propensity to engender inflammation and the efficiency of communication between neurons – also have a role to play in raising or lowering the chances of onset.

However, the interplay between genetic factors, environmental factors and what appears to be pure luck makes foreknowledge of whether Alzheimer’s will strike any individual impossible. It’s no wonder that the US National Institutes of Health does not generally recommend genetic testing as a worthwhile route for anyone wanting to know their future. After all, a result that indicates you are more likely than the average person to develop dementia is, in many ways, little more than a heavy psychological burden, to be borne until the symptoms start to appear – a scenario that keeps you stressed (a grave health risk) even if onset never happens. If the drugs don’t work yet, why would anyone sign up to be tested?

In the absence of a reliable test or cure, the best advice seems to be to delay ageing as much as possible, particularly where cardiovascular health is concerned. It’s an observation that fits with last month’s breakthrough. The plaque-provoking pathogens reach the brain through the weakening of the blood-brain barrier, a wall of cells that wraps around blood vessels and prevents foreign bodies from passing into the brain’s circulatory system. This weakening happens with age, suggesting that action to delay the degradation of the cardiovascular system will also delay the onset of Alzheimer’s disease.

Here, at least, we have some good news: the rate of appearance of dementia cases seems to be in decline. This may be a spin-off of our attempts to cut deaths from heart disease. It seems that as we take control of blood pressure and cholesterol levels, making significant improvements to our heart and circulatory function, we are unwittingly improving our cerebral health, too – almost certainly because the brain requires good blood flow to operate well.

The surest way to avoid Alzheimer’s, then, is simple to state and impossible to achieve. All you have to do is stay young. 

Michael Brooks holds a PhD in quantum physics. He writes a weekly science column for the New Statesman, and his most recent book is At the Edge of Uncertainty: 11 Discoveries Taking Science by Surprise.

This article first appeared in the 23 June 2016 issue of the New Statesman, Divided Britain